摘要
IRS1和IRS2是IRS蛋白家族和胰岛素/ IGF1信号传导中关键节点的重要代表。尽管它们的结构和功能特征非常相似,但却显示出组织特异性的差异。在这篇综述中,我们概述了IRS1和IRS2在骨骼肌和肝脏中的功能,关于它们对代谢,生长和分化的重要性。讨论了造成IRS1和IRS2疾病状态失调的机制及其后果。IRS1在骨骼肌中起主要作用.对于肌纤维的正常生长和分化,胰岛素依赖性葡萄糖摄取和糖原合成至关重要。IRS2在骨骼肌中的存在对于胰岛素诱导的葡萄糖摄取而言可以忽略不计,IRS2在肌肉中的一般作用尚未完全了解。在肝脏中,IRS1和IRS2对于冥想葡萄糖和脂质代谢的胰岛素依赖性调节是重要的,并且在昼夜调节中互补。肝脏中的IRS1在晚期再喂养期间对于信号传导更为重要,而IRS2信号通常在食物摄入后和禁食期间直接占主导地位。重要的是,肝小叶中IRS1和IRS2的表达水平不同,这可能是胰岛素抵抗现象的解释。IRS1和IRS2的肌肉或肝脏丰富度和/或磷酸化状态的失调是胰岛素抵抗,2型糖尿病和肌肉消瘦的发病机制中的重要因素。
关键词: 胰岛素受体底物,骨骼肌,肝脏,代谢,胰岛素抵抗,磷酸化,降解。
Current Medicinal Chemistry
Title:Divergent Roles of IRS (Insulin Receptor Substrate) 1 and 2 in Liver and Skeletal Muscle
Volume: 24 Issue: 17
关键词: 胰岛素受体底物,骨骼肌,肝脏,代谢,胰岛素抵抗,磷酸化,降解。
摘要: IRS1 and IRS2 are the most important representatives of the IRS protein family and critical nodes in insulin/IGF1-signaling. Although they are quite similar in their structural and functional features they show tissue-specific differences. In this review, we outline the functions of IRS1 and IRS2 in skeletal muscle and liver with regard to their importance for metabolism, growth and differentiation. Mechanisms contributing to IRS1 and IRS2 dysregulation in disease states as well as consequences thereof are discussed. IRS1 plays the dominant role in skeletal muscle. It is crucial for normal growth and differentiation of myofibers, insulin-dependent glucose uptake and glycogen synthesis. The presence of IRS2 in skeletal muscle is negligible for insulin-induced glucose uptake and the general role of IRS2 in muscle is still not fully understood. In liver IRS1 and IRS2 are important to mediate insulindependent regulation of glucose and lipid metabolism and complement each other in the diurnal regulation thereof. IRS1 in the liver is more important for signaling in the late refeeding period, whereas IRS2 signaling is mostly dominating in the period directly after food intake and during fasting. Importantly, the expression level of IRS1 and IRS2 is different within the liver lobule, which could be an explanation for the phenomenon of selective insulin resistance. Dysregulated muscular or hepatic abundance and/or phosphorylation status of IRS1 and IRS2 are important factors in the pathogenesis of insulin resistance, type 2 diabetes and muscle wasting.
Export Options
About this article
Cite this article as:
Divergent Roles of IRS (Insulin Receptor Substrate) 1 and 2 in Liver and Skeletal Muscle, Current Medicinal Chemistry 2017; 24 (17) . https://dx.doi.org/10.2174/0929867324666170426142826
DOI https://dx.doi.org/10.2174/0929867324666170426142826 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biomarkers Obtained by Non-Invasive Methods in Patients with COPD: Where do we Stand, what do we Expect?
Current Medicinal Chemistry Enantioselective, Potentiometric Membrane Electrodes (EPME) Based on Maltodextrins for the Determination of L-Vesamicol in Serum Samples
Current Pharmaceutical Analysis Transcriptional Regulation in Mammalian Pituitary Development and Disease
Current Genomics Sepsis, Coagulation and Anticoagulants
Endocrine, Metabolic & Immune Disorders - Drug Targets Expression and Function of the Endocannabinoid System in Glial Cells
Current Pharmaceutical Design Endogenous Angiogenesis Inhibitors as Therapeutic Agents: Historical Perspective and Future Direction
Recent Patents on Anti-Cancer Drug Discovery Pathophysiological Mechanisms of Stress-Induced Intestina Damage
Current Molecular Medicine Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Stem Cell Therapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets ABC Transporters, Bile Acids, and Inflammatory Stress in Liver Cancer
Current Pharmaceutical Biotechnology Peptide-Mediated Cellular Delivery of Oligonucleotide-Based Therapeutics In Vitro: Quantitative Evaluation of Overall Efficacy Employing Easy to Handle Reporter Systems
Current Pharmaceutical Design Choline Nutrition Programs Brain Development Via DNA and Histone Methylation
Central Nervous System Agents in Medicinal Chemistry Animal Models for Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Metabolic Acidosis in Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Expanding Spectrum of Sodium Potassium Chloride Co-transporters in the Pathophysiology of Diseases
Current Neuropharmacology Structural and Functional Diversity Among Eukaryotic Hsp70 Nucleotide Exchange Factors
Protein & Peptide Letters Epigenomics
Current Drug Metabolism Chromatin Remodeling, DNA Damage Repair and Aging
Current Genomics The ATP-driven Hsp60 Machinery: Biological and Clinical Implications
Current Immunology Reviews (Discontinued) From Ontology-Based Gene Function to Physiological Model
Current Bioinformatics